November 12, 2018
New data from an international study of AliveCor’s smartphone app and accompanying two-wire ECG found the mobile tool to be on par with a standard 12-lead ECG among patients presenting with ST-segment elevation myocardial infarction (STEMI).
In the study — which was conducted in conjunction with AliveCor and presented this weekend at the American Heart Association’s 2018 Scientific Session in...
September 17, 2018
Apple may be moving towards commoditizing the on-the-wrist ECG, but other companies in the space aren’t resting on their laurels. AliveCor, which has offered an smartphone-connected ECG since 2012 and a wristworn version since 2016, revealed today the company’s next direction: a six-lead ECG compatible with a smartphone.
“For the last year our challenge has not … been in making our devices...
September 13, 2018
Yesterday, Apple dropped a bombshell on the digital health world, as it is prone to do in its highly-produced launch events. While the announcement included fall detection on the Apple Watch and some improvements to heart rate monitoring, the headline was definitely the announcement that the Apple Watch Series 4 would contain an FDA-cleared ECG sensor.
While much of the reaction has been positive...
September 11, 2018
Mountain View, California-based AliveCor announced yesterday that its KardiaK Software Platform has been granted Breakthrough Device designation by the FDA.
AliveCor’s software is a neural network trained to read ECG data for elevated levels of blood potassium, a condition known as hyperkalemia that affects the kidneys.
Primarily diagnosed through invasive laboratory blood test, KardiaK would...
May 10, 2018
Digital health was a topic of discussion this week at the Heart Rhythm Society Scientific Sessions in Boston as researchers and clinicians from around the world presented their most recent study results. The focus of these studies included wearables, AI, and web-based platforms.
One new study presented at the event found that popular consumer wearables can accurately measure induced paroxysmal...
March 12, 2018
Over the weekend AliveCor announced that its technology was validated in two studies. The first found that its KardiaBand, which works as a personal electrocardiogram device, can accurately detect atrial fibrillation (AFib) when used with the Apple Watch. The second study, which was a collaboration with the Mayo Clinic found that its ECG device, when paired with AI, could detect hyperkalemia.
January 17, 2018
Editor's note: The headline of a previous version of this article incorrectly referred to Omron's devices as heart rate monitors instead of blood pressure monitors.
Last week at CES, Omron Healthcare announced two new heart monitoring devices as well as an updated version of its app to better connect the company’s products.
The first device, the Omron HeartGuide, is a watch being billed as the...
December 12, 2017
AliveCor granted patent. Consumer ECG company AliveCor was granted a patent relevant to its KardiaBand and SmartRhythm system, which launched last week. Specifically, the patent is for using data from a wearable device to detect unusual heart rates and trigger an EKG, like SmartRhythm does to detect heart arrhythmias. Notably, the patent would also describe the work being done by Apple in its...
November 30, 2017
AliveCor has launched (and received FDA clearance for) a new ECG sensor built into an Apple Watch strap, as well as an Apple Watch app on which users can see their ECG in near real-time.
The strap, called KardiaBand, is an upgraded version of a product that launched in Europe last year. But in addition to the band, AliveCor is launching SmartRhythm, a software that continuously measures heart...
September 6, 2017
AliveCor, makers of the Kardia Mobile smartphone-connected ECG, announced the results of several major studies of the technology, including one that was published online today in Circulation, the journal of the American Heart Association. The studies show the effectiveness of the technology in discovering atrial fibrillation that might otherwise have gone undetected, as well as its ease of use.